Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.

Item

http://www.wikidata.org/entity/Q45283058

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Disparate survival and risk of ...... oma: a population-based study.

@en

Disparate survival and risk of ...... oma: a population-based study.

@nl

type

Item

label

Disparate survival and risk of ...... oma: a population-based study.

@en

Disparate survival and risk of ...... oma: a population-based study.

@nl

prefLabel

Disparate survival and risk of ...... oma: a population-based study.

@en

Disparate survival and risk of ...... oma: a population-based study.

@nl

P1476

Disparate survival and risk of ...... oma: a population-based study.

@en

P2093

Shihab Ali

http://www.w3.org/2001/XMLSchema#string

P2860

Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review.

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.

Hodgkin lymphoma among US solid organ transplant recipients

InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions.

Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment.

Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 t

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.

Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)

Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial

P304

1570-1577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2013.847938

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Adam J. Olszewski

P577

2013-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257073615

http://www.w3.org/2001/XMLSchema#string

P698

24067135

http://www.w3.org/2001/XMLSchema#string